Senti Biosciences Holdings annual operating margin
2021
2022
2023
2025
Senti Biosciences Holdings's operating margin was −312,631.82% for fiscal 2025.
View full Senti Biosciences Holdings company overview| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −312,631.82% | −307943.90 pp |
| 2023 | 2023-12-31 | −4,687.92% | −2798.57 pp |
| 2022 | 2022-12-31 | −1,889.35% | −123.92 pp |
| 2021 | 2021-12-31 | −1,765.43% | — |
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −85,229.41% | −83785.01 pp |
| Q1 2026 | 2026-03-31 | −28,850.00% | −27877.18 pp |
| Q3 2023 | 2023-09-30 | −17,206.27% | −15241.38 pp |
| Q2 2023 | 2023-06-30 | −2,210.77% | −833.96 pp |
| Q1 2023 | 2023-03-31 | −1,444.40% | −210.82 pp |
| Q3 2022 | 2022-09-30 | −972.82% | +183.47 pp |
| Q2 2022 | 2022-06-30 | −1,964.89% | — |
| Q1 2022 | 2022-03-31 | −1,376.81% | — |
| Q3 2021 | 2021-09-30 | −1,233.59% | — |
| Q2 2021 | 2021-06-30 | −1,156.30% | — |
Across the available reported history, Senti Biosciences Holdings's operating margin decreased from −4,687.92% to −312,631.82%, a change of −307943.90 percentage points. The latest reported quarter, Q2 2026, shows −85,229.41%.
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Senti Biosciences Holdings filings at SEC.gov ↗